Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT05169502 Recruiting - Diabetes Clinical Trials

Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA Sequencing

CEC4DC
Start date: December 8, 2021
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to discover early biomarkers in circulating endothelial cells for diabetes complications, by investigating circulating endothelial cells in blood samples from patients with newly diagnosed proliferative diabetic retinopathy, newly diagnosed maculopathy, patients with diabetes without eye diseases, and individuals without diabetes by single-cell RNA sequencing. The single-cell RNA sequencing analysis will make it possible to fully phenotype diabetes circulating endothelial cells at single-cell level and reveal the first atlas of circulating endothelial cells in humans at both healthy and diabetes conditions.

NCT ID: NCT05169034 Terminated - Clinical trials for Diabetes Mellitus, Type 2

Feasibility Study of Blood Glucose Monitoring With the Non-invasive Medical Device D-Base

Start date: December 14, 2021
Phase:
Study type: Observational

This study aims to evaluate the feasibility of monitoring the blood glucose values by measuring the glucose in the interstitial fluid of the skin on the wrist of subjects with diabetes mellitus type 1 and 2.

NCT ID: NCT05168657 Completed - Type 1 Diabetes Clinical Trials

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Start date: March 31, 2022
Phase: N/A
Study type: Interventional

This is a study assessing the feasibility of using the insulin-only configuration of the iLet bionic pancreas with initiation in pump-naïve people with type 1 diabetes in a primary care practice with either in-person training and follow-up (PC-IP) or with training and follow-up via telehealth (PC-TH). As a comparison, the iLet will be initiated by an academic endocrinology practice with either in-person training and follow-up (EN-IP) or with training and follow-up via telehealth (EN-TH).

NCT ID: NCT05168306 Terminated - Clinical trials for Diabetes Mellitus, Type 2

T2 FSL2 Weight Loss

Start date: December 5, 2021
Phase: N/A
Study type: Interventional

To compare the impact of the FreeStyle Libre (FSL) 2 Flash Glucose Monitoring System to the current Diabetes Monitoring standard of care (SOC) on weight reduction in subjects with type 2 diabetes.

NCT ID: NCT05166525 Completed - Heart Failure Clinical Trials

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

KP NOURISH
Start date: April 27, 2020
Phase: N/A
Study type: Interventional

This study is a virtual, remote, decentralized pragmatic clinical trial comparing the efficacy of medically tailored meals alone or medically tailored meals with remote nutritional counseling compared with usual standard of care in adults with a targeted, nutrition-sensitive chronic medical condition (heart failure, diabetes mellitus, chronic kidney disease).

NCT ID: NCT05165758 Completed - Diabetes Clinical Trials

Comparison of the Quality of Life and the Level of Precarity of a Diabetic Population With and Without Foot Ulcer in Martinique

QVP-Dia
Start date: January 21, 2022
Phase:
Study type: Observational

The aim of this study is to compare quality of life of diabetics with and without foot ulcer. Investigators will compare their quality of life based on the mental health impact of foot ulcer.

NCT ID: NCT05165706 Recruiting - Obesity Clinical Trials

Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

Start date: January 31, 2019
Phase: N/A
Study type: Interventional

This 12-week controlled diet and weight intervention study seeks to define the molecular pathways that link excess body weight to the development of insulin resistance (IR). Blood, adipose and stool are sampled at three timepoints; baseline, peak weight (4 weeks) and post weight loss to monitor changes in cellular processes. Additionally, direct insulin sensitivity testing, and radiological measurement of visceral fat and intrahepatic fat content is measured at three timepoints to correlate clinical indices with cellular changes.

NCT ID: NCT05165615 Recruiting - Clinical trials for Diabetes Mellitus, Type 1

Android Artificial Pancreas System (Android APS) Versus Control-IQ

CODIAC
Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The aim of the investigator's study is to compare two different closed loop hybrid systems - certified Control-IQ and noncertified AndroidAPS in adult patients with Type 1 Diabetes (T1D), who had been using AndroidAPS previously from their own decision, during 12 weeks of follow-up.

NCT ID: NCT05163964 Completed - Clinical trials for Diabetes Mellitus, Type 2

Chronotype, Chrononutrition and Glucose Tolerance Among Prediabetic Individuals

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

Chronotype and chrononutrition, both are emerging research fields in nutritional epidemiology. However, its association with glycemic control in the global population is less clear. A better understanding of how activity/ eating time can influence glucose levels in prediabetic individuals may improve strategies for blood glucose control. The present paper aims to determine the associations of chronotype and chrononutrition with glucose tolerance among prediabetic individuals in Malaysia.

NCT ID: NCT05162183 Completed - Diabetes Clinical Trials

Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data

Start date: September 1, 2019
Phase:
Study type: Observational

Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.